Expanded Executive Committee

Expanded Executive Committee

Beatrix Benz

Head of Global Communications & Public Affairs

  • Swiss citizen
  • Bachelor of Arts, Communications and Journalism, Institute for Applied Media Science, University of Applied Science, Zurich
  • Leading positions such as Head of Communications Europe & Asia-Pacific with Novartis Animal Health, Director Global Media Relations and Global Spokesperson with Novartis International AG and Associate Director External Communications and Global Spokesperson with Nycomed International
  • Joined the company as Head of Global Communications in 2011
  • As of 2015, Head of Global Communications & Public Affairs

Dr. Behruz S. Eslami

Head of Global Regulatory Affairs

  • American citizen
  • PhD in Molecular Biology, New York Medical College, New York, USA, Bachelor of Science in Chemistry, Southern Connecticut State University, New Haven, USA
  • Leading positions such as Regulatory Affairs Director with ARES-SERONO International, Geneva, Switzerland, Group Vice President Regulatory Affairs Europe, with Genzyme Europe, Naarden, The Netherlands
  • Joined the company as Head of Global Regulatory Affairs Vifor Pharma in 2010

Dr. Thomas Kaspar

Head of Global Quality Management

  • Swiss citizen
  • Dr. Sc. Nat. ETHZ; Diploma in Economics at the Fachhochschule Nordwestschweiz
  • Worked at Streuli Pharma AG in the position of Head Quality Control Microbiology from 1996 – 2000
  • Joined the company in 2000 and worked in different positions
  • Since 2011 Head of Global Quality Management

Dr. Oliver P. Kronenberg

Group General Counsel

  • Swiss citizen
  • PhD in Law at the University of Basel; College of Europe, Bruges (Belgium), LL.M.; Fordham School of Law, New York (USA), Visiting Scholar; Admitted to the Swiss Bar
  • Associate at Sutter Attorneys-at-law in Zurich and Legal Counsel at ISL Worldwide in Zug. 2001 – 2004 he held several positions at the Fédération International de Football Association (FIFA) in Zurich, most recently as Head of General Legal. Corporate Counsel in Copenhagen at Ferring Pharmaceutical A/S. Returned to Zurich as Head of Legal at Kuros Biosurgery AG
  • Joined the company in 2008 as Head of Legal & Compliance, appointed to Chief of Staff and General Counsel Vifor Pharma in 2011
  • Since 2014 Group General Counsel

Dr. Abdul Mullick

Head of Global Strategic Marketing

  • British citizen
  • Ph.D. in Molecular Biology, Bristol University, UK
  • Leading positions such as Senior Global Brand Director, Diabetes with Novartis Pharma AG, Switzerland. European Business Unit Senior Director, Endocrine, Vice President & Head of Global Marketing, Rare Genetic Diseases and Vice President & General Manager, Endocrinology and Cardiology with Genzyme Corporation (now Sanofi), Cambridge, MA, USA
  • Joined the company as Head of Global Marketing in 2014
  • Since May 2017 Head of Global Strategic Marketing

Dr. Dirk Schrader

Head of Global Technical Operations

  • German citizen
  • PhD in Pharmaceutical Technology, WWU Muenster, Germany, Pharmaceutical Approbation, Technical University Braunschweig, Germany
  • Worked from 1992-2005 in various technical and commercial positions at Bayer, as head of a production unit in Germany, Head of Technical Operations in China, Senior Vice President International Technical Operations, General Manager for the Healthcare Businesses in Taiwan and as Head of the Diagnostics/Diabetes Care business based in Switzerland
  • Then moved to Singapore as VP Operations & Supply Asia Pacific/Japan for Bristol-Myers Squibb and in 2007 changed to AstraZeneca, first as VP Supply Asia Pacific/Japan in Singapore and from 2010 as VP Lean Operations in the UK
  • Joined the company as Head of Industrial Operations in 2012
  • Head of Global Technical Operations since June 2016

Alex Sigalas

Head of Finance, IT & Administration

  • Swiss citizen
  • Lic. oec. HSG, specialty finance and cost accounting, University of St. Gallen; Swiss CPA External Auditor with PricewaterhouseCoopers, Controller with Accenture & Société Générale Private Banking, Internal Audit Manager with Actelion & Syngenta, Finance Director Headquarters with Actelion
  • Joined the company in 2009 as CFO (Finance, IT & Admin)
  • Since 2016 Head of Finance, IT & Administration

Dr. Thierry Teil

Head of Global Medical Affairs

  • US and French citizen
  • M.D., University of Lyon Claude Bernard, Lyon, France, MBA, IGS (Institute de Gestion Sociale), IMIS (Institute of Management for Health Industries), Paris, France
  • Leading positions such as Head of Global Medical Affairs, NPS Pharma, Managing Director Russia-CIS of UCB, Head of Global Medical Affairs of UCB Belgium, Head of Alliance Management of The Medicines Company
  • Joined the company in 2016 as Head of Global Medical Affairs

Julien Vignot

Head of Investor Relations & Treasury

  • French & Swiss citizen 
  • Master of Finance, Nice, France
  • Leading positions such as Finance Director Europe of Aspreva Pharmaceuticals S.A. and Managing Director of Distrigroup S.A.
  • Joined the Galenica Group as Head of Investor Relations in 2008
  • Head of Investor Relations & Treasury and member of the Vifor Pharma Executive Committee since 2017

Dr. Stefan Wohlfeil

Chief Medical Officer & Head of Global R&D

  • German citizen
  • Medical School Düsseldorf, Germany
  • Held various positions with Bayer AG, Founder and CEO of Atani Limited London and Atani KK, Tokyo, CEO of TRIN Pharma, Switzerland, Head Clinical Pharmacology and Clinical Research with Novartis Consumer Health OTC
  • Joined the company as Head of Chemical and Preclinical Research and Development for OM Pharma and Vifor Pharma in 2012
  • Chief Medical Officer & Head of Global R&D since 2013

Beatrix Benz

Head of Global Communications & Public Affairs

  • Swiss citizen
  • Bachelor of Arts, Communications and Journalism, Institute for Applied Media Science, University of Applied Science, Zurich
  • Leading positions such as Head of Communications Europe & Asia-Pacific with Novartis Animal Health, Director Global Media Relations and Global Spokesperson with Novartis International AG and Associate Director External Communications and Global Spokesperson with Nycomed International
  • Joined the company as Head of Global Communications in 2011
  • As of 2015, Head of Global Communications & Public Affairs

Dr. Behruz S. Eslami

Head of Global Regulatory Affairs

  • American citizen
  • PhD in Molecular Biology, New York Medical College, New York, USA, Bachelor of Science in Chemistry, Southern Connecticut State University, New Haven, USA
  • Leading positions such as Regulatory Affairs Director with ARES-SERONO International, Geneva, Switzerland, Group Vice President Regulatory Affairs Europe, with Genzyme Europe, Naarden, The Netherlands
  • Joined the company as Head of Global Regulatory Affairs Vifor Pharma in 2010

Dr. Thomas Kaspar

Head of Global Quality Management

  • Swiss citizen
  • Dr. Sc. Nat. ETHZ; Diploma in Economics at the Fachhochschule Nordwestschweiz
  • Worked at Streuli Pharma AG in the position of Head Quality Control Microbiology from 1996 – 2000
  • Joined the company in 2000 and worked in different positions
  • Since 2011 Head of Global Quality Management

Dr. Oliver P. Kronenberg

Group General Counsel

  • Swiss citizen
  • PhD in Law at the University of Basel; College of Europe, Bruges (Belgium), LL.M.; Fordham School of Law, New York (USA), Visiting Scholar; Admitted to the Swiss Bar
  • Associate at Sutter Attorneys-at-law in Zurich and Legal Counsel at ISL Worldwide in Zug. 2001 – 2004 he held several positions at the Fédération International de Football Association (FIFA) in Zurich, most recently as Head of General Legal. Corporate Counsel in Copenhagen at Ferring Pharmaceutical A/S. Returned to Zurich as Head of Legal at Kuros Biosurgery AG
  • Joined the company in 2008 as Head of Legal & Compliance, appointed to Chief of Staff and General Counsel Vifor Pharma in 2011
  • Since 2014 Group General Counsel

Dr. Abdul Mullick

Head of Global Strategic Marketing

  • British citizen
  • Ph.D. in Molecular Biology, Bristol University, UK
  • Leading positions such as Senior Global Brand Director, Diabetes with Novartis Pharma AG, Switzerland. European Business Unit Senior Director, Endocrine, Vice President & Head of Global Marketing, Rare Genetic Diseases and Vice President & General Manager, Endocrinology and Cardiology with Genzyme Corporation (now Sanofi), Cambridge, MA, USA
  • Joined the company as Head of Global Marketing in 2014
  • Since May 2017 Head of Global Strategic Marketing

Dr. Dirk Schrader

Head of Global Technical Operations

  • German citizen
  • PhD in Pharmaceutical Technology, WWU Muenster, Germany, Pharmaceutical Approbation, Technical University Braunschweig, Germany
  • Worked from 1992-2005 in various technical and commercial positions at Bayer, as head of a production unit in Germany, Head of Technical Operations in China, Senior Vice President International Technical Operations, General Manager for the Healthcare Businesses in Taiwan and as Head of the Diagnostics/Diabetes Care business based in Switzerland
  • Then moved to Singapore as VP Operations & Supply Asia Pacific/Japan for Bristol-Myers Squibb and in 2007 changed to AstraZeneca, first as VP Supply Asia Pacific/Japan in Singapore and from 2010 as VP Lean Operations in the UK
  • Joined the company as Head of Industrial Operations in 2012
  • Head of Global Technical Operations since June 2016

Alex Sigalas

Head of Finance, IT & Administration

  • Swiss citizen
  • Lic. oec. HSG, specialty finance and cost accounting, University of St. Gallen; Swiss CPA External Auditor with PricewaterhouseCoopers, Controller with Accenture & Société Générale Private Banking, Internal Audit Manager with Actelion & Syngenta, Finance Director Headquarters with Actelion
  • Joined the company in 2009 as CFO (Finance, IT & Admin)
  • Since 2016 Head of Finance, IT & Administration

Dr. Thierry Teil

Head of Global Medical Affairs

  • US and French citizen
  • M.D., University of Lyon Claude Bernard, Lyon, France, MBA, IGS (Institute de Gestion Sociale), IMIS (Institute of Management for Health Industries), Paris, France
  • Leading positions such as Head of Global Medical Affairs, NPS Pharma, Managing Director Russia-CIS of UCB, Head of Global Medical Affairs of UCB Belgium, Head of Alliance Management of The Medicines Company
  • Joined the company in 2016 as Head of Global Medical Affairs

Julien Vignot

Head of Investor Relations & Treasury

  • French & Swiss citizen 
  • Master of Finance, Nice, France
  • Leading positions such as Finance Director Europe of Aspreva Pharmaceuticals S.A. and Managing Director of Distrigroup S.A.
  • Joined the Galenica Group as Head of Investor Relations in 2008
  • Head of Investor Relations & Treasury and member of the Vifor Pharma Executive Committee since 2017

Dr. Stefan Wohlfeil

Chief Medical Officer & Head of Global R&D

  • German citizen
  • Medical School Düsseldorf, Germany
  • Held various positions with Bayer AG, Founder and CEO of Atani Limited London and Atani KK, Tokyo, CEO of TRIN Pharma, Switzerland, Head Clinical Pharmacology and Clinical Research with Novartis Consumer Health OTC
  • Joined the company as Head of Chemical and Preclinical Research and Development for OM Pharma and Vifor Pharma in 2012
  • Chief Medical Officer & Head of Global R&D since 2013